SLC7A11 and neoplasm: Research has shown that tumor cells evade ferroptosis by upregulating antioxidant factors such as GPX4, SLC7A11, and FSP1. Nanoparticles loaded with gene-silencing materials or small-molecule inhibitors can directly target these antioxidant systems to reverse tumor resistance barriers (63, 64).